| Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade N McGranahan, AJS Furness, R Rosenthal, S Ramskov, R Lyngaa, ... Science 351 (6280), 1463-1469, 2016 | 3070 | 2016 |
| Genomic correlates of response to CTLA-4 blockade in metastatic melanoma EM Van Allen, D Miao, B Schilling, SA Shukla, C Blank, L Zimmer, ... Science 350 (6257), 207-211, 2015 | 2805 | 2015 |
| A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ... Cell 175 (4), 984-997. e24, 2018 | 1101 | 2018 |
| Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma D Liu, B Schilling, D Liu, A Sucker, E Livingstone, L Jerby-Arnon, ... Nature medicine 25 (12), 1916-1927, 2019 | 704 | 2019 |
| Baseline biomarkers for outcome of melanoma patients treated with pembrolizumab B Weide, A Martens, JC Hassel, C Berking, MA Postow, K Bisschop, ... Clinical Cancer Research 22 (22), 5487-5496, 2016 | 582 | 2016 |
| Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab A Martens, K Wistuba-Hamprecht, MG Foppen, J Yuan, MA Postow, ... Clinical Cancer Research 22 (12), 2908-2918, 2016 | 571 | 2016 |
| Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors D Miao, CA Margolis, NI Vokes, D Liu, A Taylor-Weiner, SM Wankowicz, ... Nature genetics 50 (9), 1271-1281, 2018 | 522 | 2018 |
| Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ... European Journal of Cancer 113, 47-54, 2019 | 494 | 2019 |
| Type I IFN s induce anti‐tumor polarization of tumor associated neutrophils in mice and human L Andzinski, N Kasnitz, S Stahnke, CF Wu, M Gereke, ... International journal of cancer 138 (8), 1982-1993, 2016 | 392 | 2016 |
| sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye, CH Kugel, ... Nature 532 (7598), 250-254, 2016 | 374 | 2016 |
| Superior skin cancer classification by the combination of human and artificial intelligence A Hekler, JS Utikal, AH Enk, A Hauschild, M Weichenthal, RC Maron, ... European Journal of Cancer 120, 114-121, 2019 | 333 | 2019 |
| Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populations CH Kugel III, SM Douglass, MR Webster, A Kaur, Q Liu, X Yin, SA Weiss, ... Clinical Cancer Research 24 (21), 5347-5356, 2018 | 328 | 2018 |
| Immunotherapy in melanoma: recent advances and future directions C Franklin, E Livingstone, A Roesch, B Schilling, D Schadendorf European Journal of Surgical Oncology (EJSO) 43 (3), 604-611, 2017 | 316 | 2017 |
| Deep neural networks are superior to dermatologists in melanoma image classification TJ Brinker, A Hekler, AH Enk, C Berking, S Haferkamp, A Hauschild, ... European Journal of Cancer 119, 11-17, 2019 | 300 | 2019 |
| A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ... European Journal of Cancer 111, 148-154, 2019 | 283 | 2019 |
| Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1-or melan-A–specific T cells B Weide, A Martens, H Zelba, C Stutz, E Derhovanessian, AM Di Giacomo, ... Clinical Cancer Research 20 (6), 1601-1609, 2014 | 283 | 2014 |
| TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma KG Griewank, R Murali, JA Puig-Butille, B Schilling, E Livingstone, ... Journal of the National Cancer Institute 106 (9), dju246, 2014 | 281 | 2014 |
| Phase II DeCOG-study of ipilimumab in pretreated and treatment-naive patients with metastatic uveal melanoma L Zimmer, J Vaubel, P Mohr, A Hauschild, J Utikal, J Simon, C Garbe, ... PloS one 10 (3), e0118564, 2015 | 255 | 2015 |
| Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised … L Zimmer, E Livingstone, JC Hassel, M Fluck, T Eigentler, C Loquai, ... The Lancet 395 (10236), 1558-1568, 2020 | 248 | 2020 |
| Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions A Sucker, F Zhao, N Pieper, C Heeke, R Maltaner, N Stadtler, B Real, ... Nature communications 8 (1), 15440, 2017 | 242 | 2017 |
